Kazuki Iwaki, Taiji Yokote, Yui Arita, Masatomo Shimizu, Tomoyuki Yamada, Yuki Kinoshita, Mitsuya Ueda, Jun Hatooka, Mayumi Fujimoto, Uta Nishiwaki, Yuki Masuda, Nobuya Hiraoka, Takuji Miyoshi, Toshikazu Akioka, Akihisa Imagawa (Osaka Japan)
Session information
Oral Session
Oral Session 2-7A PTCL/NK lymphoma: Clinicopathology
Sat. Oct 13, 2018 9:00 AM - 10:00 AM No.7 (Osaka International Convention Center, 10F 1001)
Chair: Fumihiro Ishida (Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Japan)
Yasuhiro Suzuki1,2, Takahiro Yano3, Youko Suehiro4, Hiromi Iwasaki5, Michihiro Hidaka6, Maki Otsuka7, Kazutaka Sunami8, Nobumasa Inoue9, Morio Sawamura10, Takuo Ito11, Hiroatsu Iida1, Hirokazu Nagai1 (1.Hematol., NHO Nagoya Medical Center, Nagoya, Japan, 2.Hematol., Gifu Prefectural Tajimi Hospital, Tajimi, Japan, 3.Hematol., NHO Tokyo Medical Center, Tokyo, Japan, 4.Hematol., NHO Kyushu Cancer Center, Fukuoka, Japan, 5.Hematol., NHO Kyushu Medical Center, Fukuoka, Japan, 6.Hematol., NHO Kumamoto Medical Center, Kumamoto, Japan, 7.Hematol., NHO Kagoshima Medical Center, Kagoshima, Japan, 8.Hematol., NHO Okayama Medical Center, Okayama, Japan, 9.Hematol., NHO Osaka Medical Center, Osaka, Japan, 10.Hematol., NHO Shibukawa Medical Center, Shibukawa, Japan, 11.Hematol., NHO Kure Medical Center, Kure, Japan)
Ichirou Kawano, Ikumi Yamanaka, Shinya Daitoku, Keiji Sakamoto, Kazuki Tanimoto (Hematology and Oncology Division, Japanese Red Cross Fukuoka Hospital)
[OS2-7A-4] Marked polyclonal proliferation of plasma cells in patients with AITL: three case reports
Tsutomu Shishido1, Masahiko Sumi1, Mari Kitahara1, Nozomu Uematsu1, Hiroko Kazumoto1, Takehiko Kirihara1, Keijiro Sato1, Toshimitsu Ueki1, Yuki Hiroshima1, Mayumi Ueno2, Naoaki Ichikawa2, Hikaru Kobayashi1 (1.Department of Hematology, NAGANO RED CROSS HOSPITAL, Nagano, Japan, 2.Department of Medical Oncology, NAGANO RED CROSS HOSPITAL, Nagano, Japan)
Fumihiro Kawakami1, Toru Kawakami1, Nodoka Sekiguchi1,2, Jun Kobayashi3, Taku Yamane4, Sayaka Nishina1, Hitoshi Sakai1, Kazuhiro Kimura5, Naoko Asano6, Hideyuki Nakazawa1, Fumihiro Ishida1,4 (1.Hematol.., Shinshu Univ., Matsumoto, Japan, 2.Comprehensive Cancer Ther., Shinshu Univ., Matsumoto, Japan, 3.Laboratory Med., Nagano Children's Hospital., Azumino, Japan., 4.Department of Biomedical Laboratory Medicine., Shinshu Univ., Matsumoto, Japan, 5.Cardiovascular Med., Shinshu Univ., Matsumoto, Japan, 6.Dept. of Molecular Diagnostics., Nagano Prefectural Shinshu Medical)
Hiroyuki Takahashi1, Takayuki Sakuma1, Haruka Teshigawara1, Ayako Matsumura1, Akiko Negoro1, Yuki Nakajima1, Makiko Enaka2, Takuya Miyazaki1, Maki Hagihara1, Kenji Matsumoto1, Etsuko Yamazaki3, Hideaki Nakajima1 (1.Hematol. and Clinical Immunol., Yokohama City Univ., Yokohama, Japan, 2.Pathol., Yokohama City Univ. Hosp., Yokohama, Japan, 3.Clin. Lab. Med., Yokohama City Univ Hospital, Yokohama, Japan)